Summary. Rats were bilaterally ovariectomized on Day 3 post coitum and treated daily with progesterone. Iproniazid, an inhibitor of monoamine oxidase, on Day 8 induced implantation in all rats. Indomethacin treatment prevented this effect.
Introduction
The involvement of prostaglandins (PGs) in decidual cell development (Castracane, Saksena & Shaikh, 1974) and implantation (Lau, Saksena & Chang, 1973; Castracane et al, 1974 ; Kennedy, 1977) in laboratory animals has been clearly shown. Iproniazid, a potent monoamine oxidase inhibitor recommended as having therapeutic value in mental depression (Koelle, 1970) , has an abortifacient action which is mediated through an increased endogenous production of PGs (Chatterjee, Biswas & Pal, 1974) . We therefore studied the ability of iproniazid to induce implantation in rats, and also whether indomethacin, a potent inhibitor of PG biosynthesis and release (Vane, 1971; Ferreira, Moneada & Vane, 1971 (Lau et al, 1973) . Iproniazid acts by interfering with the metabolism of catecholamines (Koelle, 1970) which can stimulate the release of prostaglandins in the spleen (Ferreira et al, 1971) . Moreover, indomethacin blocks the conversion of arachidonic acid to endoperoxides (Flower & Vane, 1974 ).
Cyclic AMP is also able to induce implantation (Webb, 1975) and ß-adrenergic catecholamine can stimulate adenylate cyclase in pigeon erythrocytes (Davoren & Sutherland, 1963) . Endometrial adenylate cyclase is also known to be stimulated by PGE-1 and PGE-2 (Bhalla, Sanborn & Korenman, 1972) . The formation of cAMP by cyclo-oxygenase in uterine decidual tissue is inhibited by indomethacin (Rankin et al, 1979) .
